checkAd

     125  0 Kommentare Y-mAbs Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference - Seite 2

    DANYELZA, and Y-mAbs are registered trademarks of Y-mAbs Therapeutics, Inc.

    Investor Contact:

    Lesen Sie auch

    Courtney Dugan
    VP, Head of Investor Relations
    cdu@ymabs.com



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 2 von 2

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Y-mAbs Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference - Seite 2 NEW YORK, Jan. 02, 2024 (GLOBE NEWSWIRE) - Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and …